Davis's Drug Guide
Update Information
Latest Update
This resource was last updated on: 2025-1-9
New topics:
- celecoxib/tramadol
- dostarlimab
- efgartigimod alfa
- elacestrant
- elranatamab
- fosdenopterin
- fruquintinib
- ganaxolone
- gepirone
- glofitamab
- ibrexafungerp
- leniolisib
- levoketoconazole
- lumasiran
- lutetium lu-177 vipivotide tetraxetan
- mannitol (inhalation)
- oxymetazoline (nasal)
Changed topics:
- acyclovir
- adenosine
- ado-trastuzumab
- afamelanotide
- aflibercept
- aminolevulinic acid
- anacaulase
- anakinra
- apalutamide
- asciminib
- atropine
- azaCITIDine
- azelastine
- azithromycin
- benralizumab
- betamethasone (systemic)
- bevacizumab
- bimekizumab
- binimetinib
- brodalumab
- canakinumab
- candesartan
- carbidopa/levodopa
- ceFAZolin
- cerliponase alfa
- certolizumab
- ciclesonide (nasal)
- ciprofloxacin
- cloZAPine
- cycloPHOSphamide
- dalteparin
- deflazacort
- denileukin diftitox
- diphenoxylate/atropine
- droNABinol
- DULoxetine
- dupilumab
- encorafenib
- EPINEPHrine
- ESTRADIOL
- fenofibrate
- filgrastim
- furosemide
- gemcitabine
- guanFACINE
- guselkumab
- HUMAN PAPILLOMAVIRUS VACCINE
- hydrALAZINE
- hydrocortisone (topical)
- isatuximab
- itraconazole
- ixekizumab
- lanadelumab
- lanthanum
- letermovir
- levoFLOXacin
- lofexidine
- methotrexate
- mitotane
- monomethyl fumarate
- mycophenolate mofetil
- nadolol
- nalmefene
- nirmatrelvir/ritonavir
- octreotide
- onabotulinumtoxinA
- osimertinib
- oxyBUTYnin
- ozanimod
- paliperidone
- pantoprazole
- pilocarpine (systemic)
- quiNINE
- ranolazine
- ribociclib
- rifAMPin
- riTUXimab
- ruxolitinib (systemic)
- sacubitril/valsartan
- salmeterol
- sarilumab
- scopolamine
- secukinumab
- selexipag
- selinexor
- sildenafil
- sipuleucel
- SITagliptin
- sodium oxybate
- sodium phenylacetate/sodium benzoate
- somatropin (recombinant) (Zomacton)
- sonidegib
- succinylcholine
- sucroferric oxyhydroxide
- tacrolimus (systemic)
- tadalafil
- tapentadol
- tavaborole
- teclistamab
- teduglutide
- telmisartan
- temozolomide
- temsirolimus
- tenapanor
- tenofovir alafenamide
- tenofovir disoproxil fumarate
- terazosin
- teriflunomide
- thioguanine
- thiotepa
- tirbanibulin
- tisotumab vedotin
- tivozanib
- tofacitinib
- toremifene
- torsemide
- trabectedin
- trametinib
- trastuzumab
- tretinoin (systemic)
- trifluridine/tipiracil
- triptorelin
- upadacitinib
- valbenazine
- valsartan
- vandetanib
- vasopressin
- vedolizumab
- venetoclax
- venlafaxine
- vigabatrin
- vilazodone
- voclosporin
- voriconazole
- vorinostat
- zolpidem
- zuranolone
Citation
Vallerand, April Hazard., et al. "Update Information." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/50998/all/Update_Information.
Vallerand AHA, Sanoski CAC, . Update Information. Davis's Drug Guide. F.A. Davis Company; 2025. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/50998/all/Update_Information. Accessed January 15, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Update Information. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/50998/all/Update_Information
Vallerand AHA, Sanoski CAC, . Update Information [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 January 15]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/50998/all/Update_Information.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Update Information
ID - 50998
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/50998/all/Update_Information
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -
